Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas N Greenwell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neuron|August 18, 2004
Neuropeptide S: a novel activating anxiolytic?George F Koob, Thomas N Greenwell
The Journal of Comparative Neurology|May 12, 2007
Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptorThomas N Greenwell, Sheryl Martin-Schild, Fiona M Inglis, et al.
The Journal of Comparative Neurology|November 21, 2002
Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental areaThomas N Greenwell, Abraham Zangen, Sheryl Martin-Schild, et al.
Pharmacology, Biochemistry, and Behavior|August 16, 2008
The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administrationThomas N Greenwell, Brendan M Walker, Pietro Cottone, et al.
Pharmacology, Biochemistry, and Behavior|March 17, 2011
Escalation patterns of varying periods of heroin accessLeandro F Vendruscolo, Joel E Schlosburg, Kaushik K Misra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Unlimited access to heroin self-administration: independent motivational markers of opiate dependenceScott A Chen, Laura E O'Dell, Michael E Hoefer, et al.
Nature Medicine|June 17, 2022
Regenerative and restorative medicine for eye diseaseRussell N Van Gelder, Michael F Chiang, Michael A Dyer, et al.
Nature Medicine|August 9, 2022
Author Correction: Regenerative and restorative medicine for eye diseaseRussell N Van Gelder, Michael F Chiang, Michael A Dyer, et al.
Stem Cell Reports|May 10, 2024
Retinal transplant immunology and advancementsVictor L Perez, Hazem M Mousa, Kiyoharu J Miyagishima, et al.
Addiction Biology|March 18, 2009
Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access ratsThomas N Greenwell, Cindy K Funk, Pietro Cottone, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neuron|August 18, 2004
Neuropeptide S: a novel activating anxiolytic?George F Koob, Thomas N Greenwell
The Journal of Comparative Neurology|May 12, 2007
Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptorThomas N Greenwell, Sheryl Martin-Schild, Fiona M Inglis, et al.
The Journal of Comparative Neurology|November 21, 2002
Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental areaThomas N Greenwell, Abraham Zangen, Sheryl Martin-Schild, et al.
Pharmacology, Biochemistry, and Behavior|August 16, 2008
The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administrationThomas N Greenwell, Brendan M Walker, Pietro Cottone, et al.
Pharmacology, Biochemistry, and Behavior|March 17, 2011
Escalation patterns of varying periods of heroin accessLeandro F Vendruscolo, Joel E Schlosburg, Kaushik K Misra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Unlimited access to heroin self-administration: independent motivational markers of opiate dependenceScott A Chen, Laura E O'Dell, Michael E Hoefer, et al.
Nature Medicine|June 17, 2022
Regenerative and restorative medicine for eye diseaseRussell N Van Gelder, Michael F Chiang, Michael A Dyer, et al.
Nature Medicine|August 9, 2022
Author Correction: Regenerative and restorative medicine for eye diseaseRussell N Van Gelder, Michael F Chiang, Michael A Dyer, et al.
Stem Cell Reports|May 10, 2024
Retinal transplant immunology and advancementsVictor L Perez, Hazem M Mousa, Kiyoharu J Miyagishima, et al.
Addiction Biology|March 18, 2009
Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access ratsThomas N Greenwell, Cindy K Funk, Pietro Cottone, et al.
Pageof 2